CFO sold ~$103K of Amphstar Pharmaceuticals, Inc.
Scheduled in advanceLoading…
AMPH · NASDAQ · Pharmaceuticals
Pharmaceuticals company based in Rancho Cucamonga, California.
In the last 90 days, no insider of Amphstar Pharmaceuticals, Inc. reported an open-market purchase and 5 open-market sales worth about $764K. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$25.37
Last 12 months
Not enough history
Market value
$1.08B
Revenue
$184M
+5.4% vs the same quarter a year earlier
Free cash flow, last 12 months
$153M
This quarter $42.7M, a year earlier $25M
Net debt
$386M
Debt $610M, cash $224M, at Jun 30, 2026
Net income, last 12 months
$78.5M
Operating profit covers interest 4.4x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 6, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
5 sales
$764K sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$720M
−1.7% vs the year before
Net income, fiscal 2025
$98.1M
As reported in the annual filing
Shares outstanding
42.5M
As of Jul 31, 2026
In fiscal 2025 the company spent $75.6M buying back its own shares. Cash actually paid, from its cash-flow statement.
CFO sold ~$103K of Amphstar Pharmaceuticals, Inc.
Scheduled in advanceStock since the trade +5.9% · S&P 500 +2.8% · to Oct 5
Amphstar Pharmaceuticals's SENIOR EVP, PRODUCTION CENTER sold $239K of Amphstar Pharmaceuticals shares. Nobody planned it ahead of time.
Officer sold ~$75K of Amphstar Pharmaceuticals, Inc.
Automatic saleStock since the trade +24.2% · S&P 500 +0.6% · to Oct 5
A board member of Amphstar Pharmaceuticals sold $162K of Amphstar Pharmaceuticals shares. Nobody planned it ahead of time.
CFO sold ~$184K of Amphstar Pharmaceuticals, Inc.
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $26.58 on Oct 6, 2025 to $25.37 on Oct 5, 2026 (-4.6%). Disclosed activity in the last 12 months: 0 insider purchases, 11 insider sales (4 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.